Basic Information
ID: ALA5109741
Type: Functional
Description: Antitumor activity against etoposide/cisplatin combination-resistant human NCI-H446 cells xenografted in BALB/c nude mouse assessed as tumor growth inhibition at 3 mg/kg, IG administered once a week and measured 3 times a week relative to control
Format: BAO_0000218
Organism: Homo sapiens
Cell type: NCI-H446
Target: NCI-H446(ALA612440)
Document: ALA5108002
Antitumor activity against etoposide/cisplatin combination-resistant human NCI-H446 cells xenografted in BALB/c nude mouse assessed as tumor growth inhibition at 3 mg/kg, IG administered once a week and measured 3 times a week relative to control: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5109741
TGI
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 458.43 | 3.07 | 3.07 |